Older adults should not be omitted from inclusion in clinical trials of SARS-CoV-2 vaccines

Since December 2019, the coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has spread worldwide, affecting millions of people and leaving hundreds of thousands dead, mostly older adults. Recently, the five main geriatric journals in the United States have joined together to produce a common text denouncing the ageism that manifested itself during the first wave of the pandemic. This text proposes four recommendations: 1) to make clinical research more inclusive for all ages, 2) to involve geriatricians and gerontologists in institutional decisions, 3) to inform policy and funding by taking into account the specific needs of vulnerable populations, and 4) to emphasize the importance of personalized approaches (adaptation of rules) for seniors, respecting autonomy, justice and charity [1].
Source: Maturitas - Category: Primary Care Authors: Source Type: research